Your browser doesn't support javascript.
loading
Oncogenic Signalling through Mechanistic Target of Rapamycin (mTOR): A Driver of Metabolic Transformation and Cancer Progression.
Rad, Ellie; Murray, James T; Tee, Andrew R.
Affiliation
  • Rad E; Division of Cancer and Genetics, Cardiff University, Heath Park, Cardiff CF14 4XN, UK. rade@tcd.ie.
  • Murray JT; School of Biochemistry & Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland. rade@tcd.ie.
  • Tee AR; School of Biochemistry & Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland. james.murray@tcd.ie.
Cancers (Basel) ; 10(1)2018 Jan 03.
Article in En | MEDLINE | ID: mdl-29301334
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancers (Basel) Year: 2018 Document type: Article Affiliation country: United kingdom Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancers (Basel) Year: 2018 Document type: Article Affiliation country: United kingdom Country of publication: Switzerland